e-learning
resources
Vienna 2009
Monday, 14.09.2009
Exacerbations of COPD and bronchiectasis: aetiology and treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Microbiological follow-up of patients with non-CF bronchiectasis related to exacerbation frequency, pulmonary function tests (PFT) and HRCT-score
J. Altenburg, C. O. Martins Jarnalo, W. G. Boersma (Alkmaar, Netherlands)
Source:
Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Session:
Exacerbations of COPD and bronchiectasis: aetiology and treatment
Session type:
Thematic Poster Session
Number:
2355
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Altenburg, C. O. Martins Jarnalo, W. G. Boersma (Alkmaar, Netherlands). Microbiological follow-up of patients with non-CF bronchiectasis related to exacerbation frequency, pulmonary function tests (PFT) and HRCT-score. Eur Respir J 2009; 34: Suppl. 53, 2355
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
The clinical significance and frequency of bronchiectasis in COPD patients
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
Relation between pulmonary function tests (PFTs) and severe asthma difficult to control
Source: Virtual Congress 2020 – Clinical parameters in severe asthma
Year: 2020
Chest radiograph, lung function tests and induced sputum in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 210s
Year: 2001
Which respiratory function test for which lung disease
Source: Annual Congress 2005 - Lung function measurements and predicted values from infants to 100-year-old adults
Year: 2005
The trend of pulmonary function tests over time in COPD patients with different levels of blood eosinophils
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Pulmonary sarcoidosis in children: a follow-up study
Source: Eur Respir J 2001; 17: 628-635
Year: 2001
Quantitative HRCT score in idiopathic pulmonary fibrosis (IPF): correlation with pulmonary function tests (PFT)
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008
Correlation between pulmonary function test (PFT) parameters and quality of life (QoL) and dyspnea in stable chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2007 - Clinical aspects in COPD
Year: 2007
The availibility of copd assessment test (CAT) in determination of risk of early hospitalization in chronic obstructive pulmonary disease patients and its correlation with pulmonary function tests, dyspnea measurement scales and St George respiratory questionnaire
Source: International Congress 2014 – COPD markers
Year: 2014
Changes in pulmonary function tests following antibiotics in infants with pulmonary exacerbation of cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment
Year: 2013
Application of impulse oscillometry and bronchial dilation test for analysis in patients with asthma and chronic obstructive pulmonary disease
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016
Microbiological features of the indicators of bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD) during remission
Source: International Congress 2019 – Clinical aspects of airway diseases
Year: 2019
Patterns of spirometry in bronchiectasis patients and relationship to markers of disease severity and hospitalisation
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Accompanying asthma in cystic fibrosis (CF) and non-CF bronchiectatic patients: could we detect it with AMP bronchoprovocation and sputum properties?
Source: Eur Respir J 2007; 30: Suppl. 51, 374s
Year: 2007
The correlation between lung sound distribution and pulmonary function in COPD patients is influenced by emphysematous lesions
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
The relation between pathogenic bacteriology in sputum and lung function in patients with acute exacerbation of COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 592s
Year: 2002
Differences in pulmonary function tests (PFTs) in patients with usual interstitial pneumonia (UIP) and nonspecific interstitial pneumonia (NSIP)
Source: Eur Respir J 2001; 18: Suppl. 33, 260s
Year: 2001
COPD: problems in diagnosis and measurement
Source: Eur Respir J 2003; 21: 4S-12S
Year: 2003
The relationship between presence of small airways disease and baseline characteristics of asthma and COPD patients
Source: International Congress 2016 – Monitoring airway diseases with different tools
Year: 2016
Can emphysema predict exacerbations and changes in PFTs in COPD?
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept